Stockscreener 앱 받기
133.13
2.12%
2.77
시간 외 거래:
133.04
-0.09
-0.07%
Biogen Inc 주식(BIIB)의 최신 뉴스
Infographic: Leqembi – A Geographical Comparison - insights.citeline.com
Biogen patents new TYK2 inhibitors - BioWorld MedTech
Former Biogen Chief Medical Officer Joins Candel Board as Prostate Cancer Drug Nears FDA Filing - Stock Titan
Neuralgia Treatment Market Deep Research with Forecast - openPR.com
Biogen Inc. (NASDAQ:BIIB) Holdings Raised by Rhumbline Advisers - MarketBeat
Biogen Announces Webcast of Annual Meeting of Stockholders - Biogen
July 25th Options Now Available For Biogen (BIIB) - Nasdaq
Neuroprotection Market Booming with Drug Development in CNS Disorders | Biogen, Teva Pharmaceuticals - openPR.com
Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia - PR Newswire Canada
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Wealth Enhancement Advisory Services LLC - MarketBeat
GAMMA Investing LLC Has $34.87 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Subcutaneous Biologics Market in 2025-2032 Detailed Study - openPR.com
4,772 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by First County Bank CT - MarketBeat
Czech National Bank Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Biogen
Relapsing Remitting Multiple Sclerosis Market Set to Witness - openPR.com
Biogen Inc (BIIB)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise - Stock Titan
Neuromuscular Disease Therapeutics Market Growth Driven - openPR.com
152,867 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
What is William Blair's Estimate for Biogen Q2 Earnings? - MarketBeat
Lansforsakringar Fondforvaltning AB publ Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
City Therapeutics Partners with Biogen - Global Legal Chronicle
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen Inc. (NASDAQ:BIIB) Holdings Raised by Centre Asset Management LLC - MarketBeat
California State Teachers Retirement System Buys 2,811 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Toronto Dominion Bank Has $11.11 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
PKO Investment Management Joint Stock Co Takes Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Farmers Trust Co. Acquires 2,012 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Lighthouse Financial LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Auxier Asset Management Sells 2,136 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Mackenzie Financial Corp - MarketBeat
GF Fund Management CO. LTD. Makes New $5.24 Million Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Progressive Supranuclear Palsy Treatment Market Set to Witness GrowthBiogen, AbbVie - openPR.com
Biogen and City Therapeutics partner to develop RNAi therapies - MSN
Biogen Inc. (NASDAQ:BIIB) Shares Sold by USS Investment Management Ltd - MarketBeat
Siemens Fonds Invest GmbH Grows Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Public Employees Retirement System of Ohio Sells 2,866 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Voloridge Investment Management LLC Invests $23.20 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $234.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Tauopathies Treatment Market Detailed in New Research ReportBiogen, AbbVie - openPR.com
Amyotrophic lateral Sclerosis Market 2025-2032: Top Trends & - openPR.com
Recombinant Dna Technology Market Generated Opportunities, - openPR.com
In Vitro Monoclonal Antibodies Market is expected to reach US$ - openPR.com
Biogen and City Therapeutics to develop RNAi therapy - Yahoo Finance
Biogen and City Therapeutics partner to advance RNAi therapies - World Pharmaceutical Frontiers
1.43%
자본화:
|
볼륨(24시간):